Cannabidiol, or CBD for short, is a natural phyto-cannabinoid (or plant-based chemical compound) found in cannabis plants, including hemp and marijuana. Unlike other cannabinoids — namely tetrahydrocannabinol, or THC — CBD does not produce any psychoactive effects, and will actually counteract these effects to a degree. CBD will induce feelings of sleepiness; for this reason, it can be an effective soporific for people who struggle to fall and/or remain asleep due to insomnia and other sleep disorders.
And we have a long way to go before we fully understand the relationship between CBD and pain regulation. But strong anecdotal evidence, combined with multiple lab tests and even some clinical trials, have established that CBD holds a lot of promise for pain relief. Or in science-speak, CBD “represents a novel class of therapeutic agents for the treatment of chronic pain.”
The CBD oil in everything that’s sold by Receptra Naturals is extracted from hemp from family-owned farms in Colorado. And the oil produced by the hemp plants – which are cultivated completely organically – is only taken from the flowering parts to ensure its purity and quality. Those of an environmentally conscious bent may therefore particularly appreciate the company’s offerings, which include CBD oil blends that aim either to boost users’ overall sense of health or, for people who are particularly physically active, to just give them a bit more pep in their steps. The most potent of these oils is, for the record, a 4,000 mg concentrate. But Receptra Naturals’ range also includes a topical cream, a skin-conditioning body butter and a CBD extract blend for pets that, the producer states, may help with anxiety, mobility and digestion in animals.
The Act authorizes the Department of Public Safety to license dispensing organizations, which function similar to compounding pharmacies. Only neurologists and epileptologists are able to offer prescriptions for CBD oil. While the law was implemented in 2015, access to CBD was delayed until 2017 to allow for additional time to create a system to ensure that distribution is confined to genuine medical necessity along with a detailed registry identifying doctors and dispensaries.